A food-safety complaint has emerged from Mumbai after a diner allegedly found a dead rat inside a Mysore masala dosa served at Radhakrishna Hotel in Borivali West. The incident was reported at the restaurant, located near Borivali West railway station, on September 29. The complaint prompted action from the Maharashtra Food and Drug Administration (FDA), which suspended the restaurant’s food business licence.&nbsp;According to the complaint, Amit Trivedi had visited the restaurant with his two brothers and son. The family ordered food at the establishment, including a Mysore masala dosa. One of Trivedi’s brothers had reportedly eaten several bites of the dosa when he noticed what appeared to be a small dead rat inside the food.&nbsp;Also Read: <a href="https://www.wionews.com/videos/maharashtra-fda-crackdown-fda-finds-serious-violations-at-popular-coffee-house-in-colaba-1789721419973">Maharashtra FDA crackdown: FDA finds serious violations at popular coffee house In Colaba</a> &nbsp;According to the complaint, the diner subsequently vomited after realising what he had eaten. The family then approached the Borivali police and reported the incident. The complaint was subsequently brought to the notice of the Maharashtra FDA for further action.<h2>FDA suspends restaurant licence</h2>Following the complaint, the FDA suspended the food business licence of Radhakrishna Hotel. The action comes amid an intensified food-safety enforcement drive in Maharashtra led by FDA Commissioner Tukaram Mundhe. The department has significantly stepped up inspections of restaurants, hotels, food manufacturers, dairies and other food businesses since Mundhe took charge earlier this year.&nbsp;Also Read: <a href="https://www.wionews.com/india-news/doctor-finds-cockroach-at-mumbai-hotel-tags-fda-chief-over-hygiene-concern-1790002135422">Doctor finds cockroach at Mumbai hotel, tags FDA chief over hygiene concern</a> Between June and August, the Maharashtra FDA conducted 12,083 inspections across the state, issued 5,269 improvement notices and suspended 603 licences, according to figures released by the department. The enforcement drive also involved seizures of food and prohibited products. The FDA’s action continued into September with a dedicated festival-season crackdown. Between September 1 and 23, the department inspected 3,068 food establishments across Maharashtra. It issued 1,506 improvement notices, suspended the licences of 248 establishments and cancelled 12 licences over serious violations. During the same period, officials seized more than 6.34 lakh kilograms of suspected adulterated or unsafe food stock valued at around Rs 9.76 crore. The department also collected 2,423 food samples for laboratory analysis.<h2>Mumbai also under FDA scanner</h2>Mumbai has been among the areas witnessing intensified enforcement. During the September 1-23 festival drive, the Mumbai division recorded 325 inspections. The FDA issued 226 improvement notices, suspended 53 licences and cancelled one licence. The wider crackdown has seen action against several well-known Mumbai eateries following inspections that reportedly detected hygiene and food-safety violations. The latest Borivali case adds to scrutiny over hygiene standards in commercial kitchens, particularly issues involving pest control, food storage and preparation practices.<h2>Investigation into rat found in dosa</h2>The precise circumstances in which the alleged rodent entered the dosa have not yet been established. Food-safety officials are expected to examine the restaurant’s kitchen, storage facilities, food preparation areas and pest-control arrangements as part of their assessment. The suspension of the restaurant’s licence means it faces immediate regulatory consequences while the matter is examined. The incident comes as the Maharashtra FDA continues a broad enforcement drive focused on food hygiene and safety standards across the state.

A diner allegedly found a dead rat inside a Mysore masala dosa at Radhakrishna Hotel in Mumbai’s Borivali West. The complaint prompted Maharashtra FDA action, with the restaurant’s food business licence suspended amid a wider state crackdown on food-safety violations.

A food-safety complaint has emerged from Mumbai after a diner allegedly found a dead rat inside a Mysore masala dosa served at Radhakrishna Hotel in Borivali West. The incident was reported at the restaurant, located near Borivali West railway station, on September 29. The complaint prompted action from the Maharashtra Food and Drug Administration (FDA), which suspended the restaurant’s food business licence. According to the complaint, Amit Trivedi had visited the restaurant with his two brothers and son. The family ordered food at the establishment, including a Mysore masala dosa. One of Trivedi’s brothers had reportedly eaten several bites of the dosa when he noticed what appeared to be a small dead rat inside the food. Also Read: Maharashtra FDA crackdown: FDA finds serious violations at popular coffee house In Colaba According to the complaint, the diner subsequently vomited after realising what he had eaten. The family then approached the Borivali police and reported the incident. The complaint was subsequently brought to the notice of the Maharashtra FDA for further action. FDA suspends restaurant licence Following the complaint, the FDA suspended the food business licence of Radhakrishna Hotel. The action comes amid an intensified food-safety enforcement drive in Maharashtra led by FDA Commissioner Tukaram Mundhe. The department has significantly stepped up inspections of restaurants, hotels, food manufacturers, dairies and other food businesses since Mundhe took charge earlier this year. Also Read: Doctor finds cockroach at Mumbai hotel, tags FDA chief over hygiene concern Between June and August, the Maharashtra FDA conducted 12,083 inspections across the state, issued 5,269 improvement notices and suspended 603 licences, according to figures released by the department. The enforcement drive also involved seizures of food and prohibited products. The FDA’s action continued into September with a dedicated festival-season crackdown. Between September 1 and 23, the department inspected 3,068 food establishments across Maharashtra. It issued 1,506 improvement notices, suspended the licences of 248 establishments and cancelled 12 licences over serious violations. During the same period, officials seized more than 6.34 lakh kilograms of suspected adulterated or unsafe food stock valued at around Rs 9.76 crore. The department also collected 2,423 food samples for laboratory analysis. Mumbai also under FDA scanner Mumbai has been among the areas witnessing intensified enforcement. During the September 1-23 festival drive, the Mumbai division recorded 325 inspections. The FDA issued 226 improvement notices, suspended 53 licences and cancelled one licence. The wider crackdown has seen action against several well-known Mumbai eateries following inspections that reportedly detected hygiene and food-safety violations. The latest Borivali case adds to scrutiny over hygiene standards in commercial kitchens, particularly issues involving pest control, food storage and preparation practices. Investigation into rat found in dosa The precise circumstances in which the alleged rodent entered the dosa have not yet been established. Food-safety officials are expected to examine the restaurant’s kitchen, storage facilities, food preparation areas and pest-control arrangements as part of their assessment. The suspension of the restaurant’s licence means it faces immediate regulatory consequences while the matter is examined. The incident comes as the Maharashtra FDA continues a broad enforcement drive focused on food hygiene and safety standards across the state.

A diner allegedly found a dead rat inside a Mysore masala dosa at Radhakrishna Hotel in Mumbai’s Borivali West. The complaint prompted Maharashtra FDA action, with the restaurant’s food business licence suspended amid a wider state crackdown on food-safety violations.

Mumbai restaurant licence suspended after diner allegedly finds rat in dosa

United States President Donald Trump announced on Tuesday (May 12) that US Food and Drug Administration (FDA) Commissioner Marty Makary is stepping down, ending a turbulent tenure marked by clashes with public health officials, pharmaceutical companies, tobacco lobbyists and conservative activists. “Marty is a terrific guy, but he's going to go on, and he's going to lead a good life,” president Trump said while speaking to reporters amid growing speculation that the administration was preparing to remove Makary from the post.&nbsp;Marty Makary, a surgeon and former Fox News contributor, became widely known during the COVID-19 pandemic for criticising mainstream medical policies and pandemic-era restrictions. After taking charge of the Food and Drug Administration (FDA), he pledged major reforms at the agency overseeing vaccines, medicines and food safety. His leadership, however, drew criticism from multiple sides. Pharmaceutical executives argued that his efforts to overhaul the drug approval system created uncertainty and delays. Public health experts accused the Food and Drug Administration (FDA) under Marty Makary of amplifying anti-vaccine narratives after the agency released a disputed memo regarding deaths allegedly linked to COVID-19 vaccines.&nbsp;Also Read: <a href="https://www.wionews.com/world/pentagon-official-says-cost-of-iran-war-has-climbed-to-about-29-billion-1778604524634">Pentagon official says cost of Iran war has climbed to about $29 billion</a>&nbsp;At the same time, anti-abortion conservatives criticized Makary for moving too slowly on a review of the abortion pill mifepristone, which has remained Food and Drug Administration-approved for more than two decades. Makary also reportedly resisted parts of the Trump administration’s push to allow flavored e-cigarettes, expressing concern about their popularity among younger consumers. His departure is the latest shake-up within the health department led by vaccine skeptic Robert F. Kennedy Jr.. The administration has already faced scrutiny over its nominations for surgeon general and leadership changes at the Centers for Disease Control and Prevention.&nbsp;<a href="https://www.wionews.com/videos/tamil-nadu-elections-defeated-dmk-leader-alleges-postal-ballot-mix-up-1778602515998/embed">https://www.wionews.com/videos/tamil-nadu-elections-defeated-dmk-leader-alleges-postal-ballot-mix-up-1778602515998/embed</a>&nbsp;Any change to the policy could significantly impact abortion access nationwide, as the FDA determines the national guidelines for prescribing the medication. Medication abortions now make up nearly two-thirds of all abortions in the United States and have contributed to a rise in procedures since the Supreme Court overturned nationwide abortion protections in 2022.

President Donald Trump announces FDA Commissioner Marty Makary’s departure after controversies involving Covid-19 vaccines, flavored vapes, mifepristone reviews and public health policy disputes

United States President Donald Trump announced on Tuesday (May 12) that US Food and Drug Administration (FDA) Commissioner Marty Makary is stepping down, ending a turbulent tenure marked by clashes with public health officials, pharmaceutical companies, tobacco lobbyists and conservative activists. “Marty is a terrific guy, but he's going to go on, and he's going to lead a good life,” president Trump said while speaking to reporters amid growing speculation that the administration was preparing to remove Makary from the post. Marty Makary, a surgeon and former Fox News contributor, became widely known during the COVID-19 pandemic for criticising mainstream medical policies and pandemic-era restrictions. After taking charge of the Food and Drug Administration (FDA), he pledged major reforms at the agency overseeing vaccines, medicines and food safety. His leadership, however, drew criticism from multiple sides. Pharmaceutical executives argued that his efforts to overhaul the drug approval system created uncertainty and delays. Public health experts accused the Food and Drug Administration (FDA) under Marty Makary of amplifying anti-vaccine narratives after the agency released a disputed memo regarding deaths allegedly linked to COVID-19 vaccines. Also Read: Pentagon official says cost of Iran war has climbed to about $29 billion At the same time, anti-abortion conservatives criticized Makary for moving too slowly on a review of the abortion pill mifepristone, which has remained Food and Drug Administration-approved for more than two decades. Makary also reportedly resisted parts of the Trump administration’s push to allow flavored e-cigarettes, expressing concern about their popularity among younger consumers. His departure is the latest shake-up within the health department led by vaccine skeptic Robert F. Kennedy Jr.. The administration has already faced scrutiny over its nominations for surgeon general and leadership changes at the Centers for Disease Control and Prevention. https://www.wionews.com/videos/tamil-nadu-elections-defeated-dmk-leader-alleges-postal-ballot-mix-up-1778602515998/embed Any change to the policy could significantly impact abortion access nationwide, as the FDA determines the national guidelines for prescribing the medication. Medication abortions now make up nearly two-thirds of all abortions in the United States and have contributed to a rise in procedures since the Supreme Court overturned nationwide abortion protections in 2022.

Donald Trump says Food and Drug Administration chief Marty Makary is leaving after controversies over vaccines, vaping, drug reviews and public health policies

FDA Commissioner Marty Makary resigns after clashes over vaccines and vapes. Who is he?

fda-commissioner

Fda Commissioner, News on Fda Commissioner, stories on Fda Commissioner, articles on Fda Commissioner, Fda Commissioner stories at Wion, Fda Commissioner news, Fda Commissioner latest news

fda commissioner

Mumbai restaurant licence suspended after diner allegedly finds rat in dosa

Trump confirms exit of FDA Commissioner Marty Makary amid mounting controversies